Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases
Resumen
Introduction: Emerging infectious diseases’ diagnosis has been a major problem in most hospitals and other senior care facilities, especially for the current Coronavirus Disease 2019 (COVID-19). The various clinical manifestations, and the several radiology and laboratory data combined with the misleading test results for identifying the virus, are responsible for certain misdiagnoses, especially for suspected cases that visit the emergency department and require urgent management and further treatment. Areas Covered: The major challenges for emerging infectious diseases’ molecular diagnosis are being described here on a great scale, and, finally, strategies for a precise and on-the-spot molecular diagnosis are thoroughly discussed. Related literature was searched using the PubMed, Science Direct, and EMBASE databases published until May 2022 on the general information for viral infections and relevant false test results. Expert Opinion: Emerging diseases’ molecular diagnosis via current common diagnostic assays seems to be extremely tricky, and front-line physicians and other senior care facilities should be able to recognize some falsely diagnosed cases or even prevent their existence. Further biotechnologic revolution concerning viral molecular diagnostics will be evident in the near future, thus new methods’ limitations should be highlighted to physicians from the very beginning of their performances and wide utilization. © 2022 Informa UK Limited, trading as Taylor & Francis Group.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
MRSA infections among patients in the emergency department: A European multicentre study
Bouchiat C., Curtis S., Spiliopoulou I., Bes M., Cocuzza C., Codita I., Dupieux C., Giormezis N., Kearns A., Laurent F., Molinos S., Musumeci R., Prat C., Saadatian-Elahi M., Tacconelli E., Tristan A., Schulte B., Vandenesch F., Monneuse O., de Francisco T., Casella P., Erbizzoni S., Melzi S., Oggioni D., Sala R., Calaresu E., Efthimia P., Markos M., Petinaki E., Schroeder W., on behalf of the ESCMID Study Group on Staphylococci and Staphylococcal Infections (ESGS) (2017)Background: MRSA is a therapeutic concern worldwide, and a major agent of community-acquired skin and soft tissue infections (CA-SSTIs). While the US epidemiology of MRSA in CA-SSTIs is well described and reports the high ... -
Emergence of a mupirocin-resistant, methicillin-susceptible Staphylococcus aureus clone associated with skin and soft tissue infections in Greece
Giormezis N., Doudoulakakis A., Tsilipounidaki K., Militsopoulou M., Kalogeras G., Stamouli V., Kolonitsiou F., Petinaki E., Lebessi E., Spiliopoulou I. (2021)Background: Staphylococcus aureus causes various infections, including skin and soft tissue infections (SSTIs). In this study, methicillin-susceptible S. aureus (MSSA) from SSTIs among patients in three tertiary-care ... -
Emerging molecular networks common in ionizing radiation, immune and inflammatory responses by employing bioinformatics approaches
Georgakilas, A. G.; Pavlopoulou, A.; Louka, M.; Nikitaki, Z.; Vorgias, C. E.; Bagos, P. G.; Michalopoulos, I. (2015)Efficient radiation therapy is characterized by enhanced tumor cell killing involving the activation of the immune system (tumor immunogenicity) but at the same time minimizing chronic inflammation and radiation adverse ...